NCT06421324Recruiting
Personalised Health Recommendations to the General Population Through an Integrated AI Guided
Interventional Study Focused on Providing Personalised Health Recommendations to the General Population Through an Integrated AI Guided App as a Strategy for Gastric Cancer Prevention (AIDA)
Source: ClinicalTrials.gov · Last updated 27 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This clinical study aims to be used to implement and validate the AIDA tool in two phases: * Phase 1: Risk stratification and personalised recommendations \& Model development * Phase 2: Mechanistic Model (Bioresource) development \& testing
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- First submitted
- 8 May 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06421324
What you commit to
- Study type: Interventional
- Planned participants: 450
- From 1 Jun 2024 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have received antimicrobials during the four weeks prior to the endoscopy
- Patients who have received proton pump inhibitors and/or bismuth-based treatments at least two weeks prior to the endoscopy
Other illness
- Patients to whom an endoscopy is performed for the follow-up of another illness such as oesophageal varices and/or for therapy such as endoscopic dilation, feeding tube placement or endoscopic resection
- Subjects with a clinical diagnosis of gastric diseases other than GIM or GC
Age
- Subjects for whom clinical data are not available: H. pylori status, eradication treatment, sex, age, tobacco smoking, and first-degree family history of gastric cancer
Other
- Subjects who lack the mental capacity to understand the nature and requirements of the study and who lack the ability to give informed consent
Who the study is looking for
- Subjects ≥ 18 years old with a diagnosis of GIM or previous or current H. pylori infection, to whom a gastroscopy is indicated within clinical care
- Availability of a signed informed consent form to participate in the study
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Clinico Universitario de Valencia Coordinator of this site? Confirm its status | Valencia | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.